2018-05-29

[#DIV28SUPER] Editorial Fellowship Available for Experimental and Clinical Psychopharmacology

Experimental and Clinical Psychopharmacology announces an opening for an Editorial Fellow position, beginning January 1, 2019. The position is open to qualified candidates who hold the rank of Assistant Professor (or equivalent) and will last one year. During this time, the selected Fellow will work closely with the journal's Editor, Dr. William W. Stoops, to develop editorial and publishing proficiency, enrich scientific knowledge and bolster written communication skills. It is anticipated that the Fellow will manage approximately one manuscript per month. This process will include identifying reviewers, making an editorial decision based on review and shepherding the manuscript through to publication if accepted, all with guidance from Dr. Stoops. The successful candidate will also be expected to participate in monthly meetings with Dr. Stoops to ensure goals are met and problems are identified and addressed. The majority of these meetings will be phone conferences, although in-person meetings at scientific conferences are also possible. Upon successful completion of the fellowship, the Editorial Fellow will become a member of the journal's editorial board. All applications should include the following: 1) an interest statement, 2) a curriculum vitae and 3) three recommendation letters. Application materials are due to Dr. Stoops (william.stoops@uky.edu) on September 1, 2018 at 5 PM Eastern time and should be submitted as a single pdf file. Applications will be reviewed by members of the Experimental and Clinical Psychopharmacology editorial board for strength of the interest statement, research and publishing experience, manuscript review experience and enthusiasm of the recommendation letters. The top candidate will be notified of her/his selection by December 1, 2018. Address any questions to Dr. Stoops at william.stoops@uky.edu.



               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
phone: (859) 257-5383
facsimile: (859) 257-7684


Professor
University of Kentucky College of Medicine
Department of Behavioral Science
Department of Psychiatry
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology

Director
Regulatory Knowledge and Support Core
Component Lead
Research Methods
University of Kentucky Center for Clinical and Translational Science

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.

2018-05-15

[#DIV28SUPER] Special Issue Call for Papers

Call for Papers: Experimental and Clinical Psychopharmacology

 

Special Issue for April 2019 on:

Therapeutic and Abuse-Related Effects of Cannabis and Cannabinoids

 

This special issue will provide an overview of current research on cannabis and cannabinoids with an emphasis on issues related to their legalization for medical and recreational use.  We encourage submission of review articles and original research reports in this area, including the following topics: therapeutic efficacy of cannabis and cannabinoids across different disease conditions; etiology of cannabinoid use disorders; consequences of cannabinoid exposure during pregnancy, adolescence, and adulthood; development of forensic testing for detecting acute cannabis intoxication;  influence of route of cannabinoid administration on therapeutic effects and abuse liability;  variations in THC content across cannabis strains and cannabinoid-enriched products, and implications for use; current federal restrictions on cannabis research; prevalence of synthetic cannabinoids, issues with their regulation, mechanisms of action and consequences of their use; and changes in public perceptions of perceived harm of medicinal and recreational cannabis and cannabinoid use.

 

Researchers in this area may submit review articles or primary research reports to Experimental and Clinical Psychopharmacology to be considered for inclusion in this special issue. Manuscripts should be submitted as usual through the APA Online Submission Portal (http://pha.edmgr.com/), and the cover letter should indicate that the authors wish the manuscript to be considered for publication in the special issue on Therapeutic and Abuse-Related Effects of Cannabis and Cannabinoids.  All submissions will undergo our normal peer review. Manuscripts received no later than October 1, 2018 will be considered for inclusion in the special issue. We strongly encourage individuals to contact the guest editors in advance with their ideas and a draft the title and abstract.

 

Questions or inquiries about the special issue can be directed to the Guest Editors of the issue, Ashley Acheson, PhD, awacheson@uams.edu, or William Fantegrossi, wefantegrossi@uams.edu, or the Editor, William Stoops, PhD at william.stoops@uky.edu.



               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
phone: (859) 257-5383
facsimile: (859) 257-7684


Professor
University of Kentucky College of Medicine
Department of Behavioral Science
Department of Psychiatry
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology

Director
Regulatory Knowledge and Support Core
Component Lead
Research Methods
University of Kentucky Center for Clinical and Translational Science

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.

2018-05-14

[#DIV28SUPER] Job opening

Se below...
From: Brian Borsari, PhD <brian.borsari.sfva.ucsf@gmail.com>
Sent: Monday, May 14, 2018 9:59:25 AM
To: Adam Matthew Leventhal
Subject: Can you post to Div 28 list serve and to any interested colleagues?
 

The San Francisco VA Health Care System Mental Health Service and Department of Psychiatry, University of California, San Francisco invite applications for an 8/8th behavioral health research psychologist. We are seeking applicants who are Principal Investigator (PI), Co-PI, or Co-Investigator on externally funded research projects, and the candidate will be expected to maintain an active portfolio of externally funded clinical research at a high level of investigative independence involving complex research programs and/or multi-site research trials or collaborations. Candidate will also perform direct clinical care as part of Primary Care Mental Health Integration team, with an emphasis on behavioral health in the primary care setting (e.g., mood and anxiety management secondary to health conditions, chronic pain, weight loss, diabetes management, tobacco use cessation, sleep hygiene). Programmatic support for the position also includes start-up funding and designated office and research space within the Mental Health Service at the SFVA. The candidate will be proposed for appointment as an affiliate-paid Professor in the In Residence series at a rank and series commensurate with experience. Candidates must be a US citizen and have a PhD/PsyD in clinical/counseling psychology from an American Psychological Association (APA) approved program and completion of an APA-approved internship. Position is posted for current VA employees at https://www.usajobs.gov/GetJob/ViewDetails/499473300 and for non-VA employees athttps://www.usajobs.gov/GetJob/ViewDetails/499473400  

For more information, contact Brian Borsari, PhD at 415-221-4810 x26078 or brian.borsari@ucsf.edu or brian.borsari@va.gov. Applications due by 6/1/2018.

 


On 9 April 2018 at 16:43, Adam Leventhal <adam.leventhal@usc.edu> wrote:
Dear Colleagues:

The American Psychological Association (APA) Division on Psychopharmacology and Substance Abuse (Division 28) is seeking nominations for new Fellows. As described by APA, "Fellow status is an honor bestowed upon APA members who have shown evidence of unusual and outstanding contributions or performance in the field of psychology. Fellow status requires that a person's work has had a national impact on the field of psychology beyond a local, state, or regional level. A high level of competence or steady and continuing contributions are not sufficient to warrant fellow status. National impact must be demonstrated."

In Division 28 a successful nominee will typically be 10+ years post-doctorate, have a track record of substantial external funding and publication productivity, and can document the national impact of their research on the psychopharmacology and substance abuse fields.

If you would like to nominate a colleague for consideration for Fellow status, please send their CV and contact information to the address below. You may also nominate somebody who is already an APA Fellow (with relevance to our Division), but who is not yet a Fellow of Division 28. Self-nominations are also welcomed.

Contact Information for Fellow Nominations:

Adam Leventhal, Ph.D.
adam.leventhal@usc.edu
APA Division 28 Fellows Chair

Don't hestitate to contact me if you had any further questions.

Best,

Adam
--
Adam Leventhal, Ph.D.
Director, USC Health, Emotion, & Addiction Laboratory
Professor of Preventive Medicine and Psychology
USC Norris Comprehensive Cancer Center
Keck School of Medicine
University of Southern California
2250 Alcazar St., CSC 271
Los Angeles, CA 90033
Phone: 323-442-8222
Fax: 323-442-2359
heal.usc.edu

_______________________________________________
Apadiv50-forum mailing list
Apadiv50-forum@mailman.yale.edu
https://mailman.yale.edu/mailman/listinfo/apadiv50-forum




--
******************************************************************************************
Brian Borsari, Ph.D.

Health Behavior Coordinator/Clinical Psychologist

Building 8, Room 108

San Francisco VA Medical Center (116B)

4150 Clement Street

San Francisco, CA 94121

Phone: (415) 221-4810 x26078

FAX: (415) 750-6987


Professor in Residence

Department of Psychiatry

UCSF Weill Institute for Neurosciences

University of California, San Francisco

http://ncire.org/research/researcher_directory/Brian-Borsari-PhD/

http://profiles.ucsf.edu/brian.borsari


Adjunct Professor of Behavioral and Social Sciences
Center for Alcohol and Addiction Studies
Brown School of Public Health


******************************************************************************************






2018-05-08

[#DIV28SUPER] 14th Annual Mechanisms of Behavior Change Satellite Session June 16 (free one day meeting)

Registration for the 14th Annual Mechanisms of Behavior Change satellite session on June 16th in San Diego is still open at https://casaa.unm.edu/mechanismsofchange.

 

The theme for this year is “Transbehavioral Mechanisms and Processes of Change” and features seven leaders in the field of addiction, science of behavior change, and quantitative methods. This free one-day meeting also includes informal networking opportunities, and an update on funding initiatives from the National Institute on Alcohol Abuse and Alcoholism and the Science of Behavior Change program (NIH Common Fund).

 

At our website you will find a registration form for the upcoming session, which features exciting talks on the science of behavior change by Drs. Lisa Marsch, Kathleen Carroll, Allison Harvey, Jun Ma, and Joshua Smythe, as well as a keynote methods address by Dr. Kevin Grimm.  We would also appreciate if you forward this email to colleagues and trainees who might be interested in attending. 

 

To register and find more information about the day please go to our website at:
https://casaa.unm.edu/mechanismsofchange

 

 

Thank you for your time and interest,

Katie Witkiewitz and Mitch Karno

MOBC Satellite Planning Committee

 

Katie Witkiewitz, PhD

Professor

Department of Psychology

Center on Alcoholism, Substance Abuse, and Addictions

MSC03-2220

University of New Mexico

Albuquerque NM 87131

Office phone: 505-277-5953

Vmail: 505-925-2334

Fax: 505-277-1394

http://casaa.unm.edu/kwitkiewitz.html